Advent International to acquire a significant stake in Suven Pharmaceuticals
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
The project will generate and supply green energy to fulfill about 50% present consumption of the company
The scheme is subject to statutory and regulatory approvals as may be necessary.
Her previous role at Novartis, where she was general manager, data & digital, in global drug development, also included accountability for driving the DCT strategy, programs and platforms
The investment will enable the company to enter European markets as well as enhance margins in current markets
To focus on providing safer burn treatments for women and armed forces
They also released the Operational Guidelines for Wellness activities at AB-HWCs
Company to open new headquarters in 2024
Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to medical and paramedical staff
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
Subscribe To Our Newsletter & Stay Updated